Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution.
AUTOR(ES)
McKenna, C. J.
RESUMO
OBJECTIVES: To compare HLA distribution in familial and non-familial dilated cardiomyopathy, because a serum marker that could identify families at risk of developing dilated cardiomyopathy should be of use in screening for the disease. PATIENTS: 100 patients with dilated cardiomyopathy. METHODS: 200 first degree relatives from 56 of the proband families were screened for dilated cardiomyopathy by echocardiography. The HLA profile of the patients with dilated cardiomyopathy, as well as of the familial and non-familial subgroups, was compared with that of 9000 normal controls. RESULTS: The familial prevalence of dilated cardiomyopathy in this patient group was "definite" in 14 of 56 (25%) and "possible" in 25 of 56 (45%). The HLA-DR4 frequency in the 100 patients with dilated cardiomyopathy was similar to that in the 9000 controls (39% v 32%). However, the DR4 subtype was significantly more common in the 25 probands with a familial tendency to dilated cardiomyopathy than in the 31 probands with non-familial dilated cardiomyopathy (68% v 32%; P < 0.05). CONCLUSIONS: The present finding supports an HLA linked predisposition to familial dilated cardiomyopathy. The HLA type DR4 was significantly more common in familial than in non-familial cases. The DR4 halotype was associated with two thirds of the families at risk for dilated cardiomyopathy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=484799Documentos Relacionados
- Familial aggregation of idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families.
- HLA antigens in idiopathic dilated cardiomyopathy.
- Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use
- Familial dilated cardiomyopathy: a worse prognosis compared with sporadic forms.
- Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy.